The one-month prevalence was the most common prevalence period reported and ranged between 27% and 49%.
The occurrence of C. canis, R. sanguineus, T. canis, Ancylostoma sp. and T. vulpis was most common (prevalence 14.4% to 41.7%).
A total of 2963 PIMs and 2315 PPOs were identified during this study period.> -wrap-foot> andM and PPO screening tools are not mutually exclusive, overall prevalence of PIMs and PPOs accounts for any overlap The most common (prevalence >2%%) individual PIM criteria and PPO criteria are reported in Tables 2 and 3, respectively.
In the Rochester, Minnesota, USA study [ 10], AR was most common (59% prevalence) among people whose asthma was diagnosed before age 25, and AR was relatively uncommon (15%) among those whose asthma was diagnosed after age 40 (9% of all subjects).
In United States, the National Comorbidity Survey Replication (NCS-R) study using the WHO WMH Survey Initiative version of the CIDI (WMH-CIDI) found a 12-months prevalence of anxiety of 18.1%% among adults in the community [ 8]. Specific phobia was the most common with a prevalence of 8.7 %, while agoraphobia without panic disorder was the least common, with a prevalence of 0.8%%.
According to the Global Burden of Disease 2010, tension-type headache is the second most common clinical condition (prevalence, 20.8%) preceded only by dental caries and followed by migraine (prevalence, 14.7%)[1].
In cats, Toxocara cati was the most common helminth with prevalence values ranging from 1.5% to 10% [ 7, 8, 10, 13].
Among these mental illnesses, oppositional defiant disorder and anxiety disorder were the most common with a prevalence of 6.9% and 6.8%, respectively [ 4].
4 The objective of the current analysis of patients with moderate-to-severe HS was to identify the most common comorbidities, their prevalence according to the level of HS disease burden (high vs. medium) and any association between baseline characteristics and the risk for the comorbidity.
Various genetic mutations have been detected in PD, with the G2019S mutation of the leucine rich repeat kinase 2 (LRRK2) gene being the most common with a prevalence in PD patients of 1 2% in the UK and USA, rising to 10% in Ashkenazi Jews and 39% among the North African Berber population (2).
Recent epidemiological studies show that up to 5% of youths suffer from anxiety complaints that are severe enough to interfere with their daily functioning [ 1, 2]. Specific phobia, social phobia, generalized anxiety disorder, and separation anxiety disorder are most common, with mean prevalence rates up to 5% [ 3].
